BUFFALO, N.Y. (AP) _ Athenex Inc. (ATNX) on Monday reported a loss of $27.1 million in its fourth quarter.
On a per-share basis, the Buffalo, New York-based company said it had a loss of 41 cents.
The biopharmaceutical company posted revenue of $21.3 million in the period.
For the year, the company reported that its loss narrowed to $117.4 million, or $1.82 per share. Revenue was reported as $89.1 million.
Athenex shares have declined 7 percent since the beginning of the year. The stock has declined 29 percent in the last 12 months.
This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on ATNX at https://www.zacks.com/ap/ATNX